Literature DB >> 17641500

From new frontiers to new standards of practice: advances in radiotherapy planning and delivery.

James A Purdy1.   

Abstract

Radiation therapy treatment planning and delivery capabilities have changed dramatically since the introduction of three-dimensional treatment planning in the 1980s and continue to change in response to the implementation of new technologies. CT simulation and three-dimensional radiation treatment planning systems have become the standard of practice in clinics around the world. Medical accelerator manufacturers have employed advanced computer technology to produce treatment planning/delivery systems capable of precise shaping of dose distributions via computer-controlled multileaf collimators, in which the beam fluence is varied optimally to achieve the plan prescription. This mode of therapy is referred to as intensity-modulated radiation therapy (IMRT), and is capable of generating extremely conformal dose distributions including concave isodose volumes that provide conformal target volume coverage and avoidance of specific sensitive normal structures. IMRT is rapidly being implemented in clinics throughout the USA. This increasing use of IMRT has focused attention on the need to better account for both intrafraction and interfraction spatial uncertainties, which has helped spur the development of treatment machines with integrated planar and volumetric advanced imaging capabilities. In addition, advances in both anatomical and functional imaging provide improved ability to define the tumor volumes. Advances in all these technologies are occurring at a record pace and again pushing the cutting-edge frontiers of radiation oncology from IMRT to what is now referred to as image-guided IMRT, or simply image-guided radiation therapy (IGRT). A brief overview is presented of these latest advancements in conformal treatment planning and treatment delivery.

Entities:  

Mesh:

Year:  2007        PMID: 17641500     DOI: 10.1159/000106026

Source DB:  PubMed          Journal:  Front Radiat Ther Oncol        ISSN: 0071-9676


  5 in total

Review 1.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

2.  Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury.

Authors:  Jeff S Isenberg; Justin B Maxhimer; Fuminori Hyodo; Michael L Pendrak; Lisa A Ridnour; William G DeGraff; Maria Tsokos; David A Wink; David D Roberts
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

3.  Quality assurance in radiotherapy on a national level; experience from Norway: the KVIST initiative.

Authors:  Taran Paulsen Hellebust; Ingrid Espe Heikkilä; Gunilla Frykholm; Sverre Levernes; Dag Clement Johannessen; Hans Bjerke; Hilde Olerud
Journal:  J Radiother Pract       Date:  2013-04-22

4.  Correlation of 3DCRT and Open Field Treatment Techniques in Advanced Head and Neck Cancer Patients Treated by Chemoradiation.

Authors:  Anjali Sachan; Seema Gupta; Navin Singh
Journal:  J Biomed Phys Eng       Date:  2022-02-01

5.  The emerging role of IG-IMRT for palliative radiotherapy: a single-institution experience.

Authors:  R Samant; L Gerig; L Montgomery; R Macrae; G Fox; B Nyiri; K Carty; M Macpherson
Journal:  Curr Oncol       Date:  2009-05       Impact factor: 3.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.